The John Vane Memorial Symposium on Prostacyclin Science and Pulmonary Vascular Disease was held at the Royal Society, London, UK again this year and it was wonderful to see everyone in person!
Those of you who attended this year will be able to revisit the presentations using the links below (your password has been emailed to you). We hope you enjoy.
Chris Thiemermann - Welcome
Marc Humbert - 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of PH
Vallerie Mclaughlin - Risk Management and Medical Therapy for PH
Ardeschir Ghofrani - New Study Designs for Clinical Trials in PH
David Kieley - Multimodality Imaging and AI in the Diagnosis and Assessment of PH
Jim White - Freedom EV: Risk Scores, Events and Mortality
Sandeep Sahay - Assessed versus Actual Risk of PH?
Franck Rahaghi - What is a Disease-Modifying Therapy in PH?
Vinicio de Jesus Perez - Global Perspective of Patient Care Access
John Ryan - Patient Perspective in Treatment Planning in PH
George Giannakoulas - Pulmonary Hypertension in Congenital Heart Disease?
Martin Wilkins - The use of remote haemodynamic monitoring in drug development
Michele D’Alto - Combination therapies in PAH: Are Prostacyclins dispensable?
Mark Toshner - Autoimmunity and Idiopathic Pulmonary Hypertension
Dario Vizza - Pulmonary Hypertension in Patients with COPD
Allan Lawrie - Molecular Subsets of Pulmonary Hypertension
